Skip to main content
Premium Trial:

Request an Annual Quote

Roland Diggelmann, Michael Heuer

Roland Diggelmann will be stepping down as CEO of Roche Diagnostics, effective Sept. 30, to pursue his career elsewhere. Michael Heuer, Roche Diagnostics' region head for Europe, the Middle East, Africa, and Latin America, will step in as interim CEO of Roche's diagnostics division and will become a member of the corporate executive committee. He was previously with Boehringer Mannheim, which Roche acquired in 1998. Heuer holds a PhD in chemistry from the University of Kiel in Germany.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.